# BPC-157 vs Larazotide: How They Differ | PepVault

Source: https://pepvault.app/peptides/compare/bpc-157-vs-larazotide

Last updated: 2026-09-30

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Comparisons](https://pepvault.app/peptides/compare) BPC-157 vs Larazotide

Compared side by side

# BPC-157 vs larazotide: how they differ

Reviewed September 2026 [How we check the library](https://pepvault.app/about#library) [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The short answer

Both are aimed at the gut, from different angles: larazotide is an oral drug candidate that blocks the zonulin pathway to keep the junctions between gut cells closed, and BPC-157 is a peptide that, in animal studies, protects and repairs the gut lining. Larazotide reached phase 3 trials in celiac disease but was never approved, and in its celiac trials the gut-permeability test didn’t change. Larazotide is taken by mouth 3 times a day with meals; BPC-157 is mostly injected, once or twice daily.

## Side by side

| Compared | [BPC-157](https://pepvault.app/peptides/bpc-157) | [Larazotide](https://pepvault.app/peptides/larazotide) |
| --- | --- | --- |
| Category | Healing & recovery | Healing & recovery |
| Also known as | Body Protection Compound 157, BPC157 | AT-1001, Larazotide Acetate |
| What it is | A peptide derived from a protective protein in your stomach. | An oral drug candidate aimed at the 'gates' between cells in your gut lining: it blocks the zonulin pathway to keep them closed. |
| How it works | Synthetic pentadecapeptide derived from a protein in human gastric juice. In animal studies it promotes angiogenesis, speeds tendon, ligament and muscle healing, modulates dopamine and serotonin systems, and protects the gut lining. | Tight junction regulator that blocks the zonulin pathway to reduce gut permeability; in cell and animal studies it tightens the junctions between gut cells. In human celiac trials the gut-permeability test didn't change. Phase 2 trials were run in celiac disease, and a phase 3 was stopped in 2022 after an interim analysis. |
| Commonly reported | Faster recovery from tendon and ligament injuries, and a calmer gut. It's one of the most widely used peptides in the community; the human studies so far are three small uncontrolled pilots. | Less bloating and post-meal discomfort, though many notice little. It reached phase 3 trials in celiac disease but was never approved. |
| Studied range | Research range: 200–500 mcg. Studied in research — not a recommendation. | Research range: 0.5–1 mg. Studied in research — not a recommendation. |
| How often | Once or twice daily | 3x daily with meals |
| Half-life | ~4–6 hours (community estimate for SubQ; not measured in people: in rats and dogs it cleared in under 30 minutes) | Very short (local gut action) |
| Route | SubQ injection, IM injection, Oral (less studied) | Oral |
| Typical run | Typically 4–12 weeks. Many run until injury resolves then stop. Some run indefinitely at lower doses. Opinions vary widely. | Typically used for 4–12 weeks alongside gut healing protocols. |
| Evidence | Emerging: primarily preclinical / limited human data | Moderate: animal studies + some human data |
| Common side effects | Nausea (rare), injection site irritation, vivid dreams, dizziness | Generally well tolerated, mild GI upset, nausea |

Typical run: Community practice — opinions vary. Not a clinical recommendation.

<!--promo-->

PepVault for iPhone

## Taking BPC-157 or larazotide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

### BPC-157

- Day 1–7 Week one: early hints, for some
- Day 7–14 Pain often starts to ease
- Day 14–21 Pain often eases by week three
- Day 21–28 Many report a calmer gut
- Day 28–42 The slower part of repair
- Day 42–56 Six weeks in: taking stock
- Day 84+ Past week 12, the data runs thin

[Every card for BPC-157, with its sources](https://pepvault.app/peptides/bpc-157#weeks)

### Larazotide

- Day 1–14 Early days at the gut lining
- Day 14–42 What users notice in weeks 2 to 6
- Day 42–84 Taper or maintain

[Every card for larazotide, with its sources](https://pepvault.app/peptides/larazotide#weeks)

## Together or one or the other

BPC-157 and larazotide are a common stack: larazotide lists BPC-157 among its common stacks.

Community · Larazotide

### Gut repair trio

Three layers of the same problem: larazotide targets the gaps between gut cells, BPC-157 supports deeper repair of the gut lining, and KPV damps the inflammation in between. A common practitioner stack for gut recovery. Commonly reported: calmer digestion over several weeks.

## With this comparison

### BPC-157

- [BPC-157: the full reference](https://pepvault.app/peptides/bpc-157)
- [BPC-157 dose guide](https://pepvault.app/lab/dosage/bpc-157)

### Larazotide

- [Larazotide: the full reference](https://pepvault.app/peptides/larazotide)
- [Larazotide dose guide](https://pepvault.app/lab/dosage/larazotide)

### Mixing charts

- [BPC-157 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-5mg)
- [BPC-157 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-10mg)

### Studies

- [BPC-157: 10 of 12 women reported full interstitial cystitis relief](https://pepvault.app/research/bpc-157-lee-2024)
- [BPC-157: 14 of 16 reported knee pain relief in a chart review](https://pepvault.app/research/bpc-157-lee-2021)
- [BPC-157 closed duodenocolic fistulas in rats](https://pepvault.app/research/bpc-157-vukusic-2024)
- [All 6 studies](https://pepvault.app/research#bpc-157)
- [Larazotide: eased GI symptoms in celiac patients on gluten challenge](https://pepvault.app/research/larazotide-hoilat-2022)
- [Larazotide: no gut permeability rise after gluten in celiac patients](https://pepvault.app/research/larazotide-paterson-2007)
- [All 2 studies](https://pepvault.app/research#larazotide)

### Compared with

- [Retatrutide vs BPC-157](https://pepvault.app/peptides/compare/retatrutide-vs-bpc-157)
- [Semaglutide vs BPC-157](https://pepvault.app/peptides/compare/semaglutide-vs-bpc-157)
- [BPC-157 vs TB-500](https://pepvault.app/peptides/compare/bpc-157-vs-tb-500)
- [KPV vs BPC-157](https://pepvault.app/peptides/compare/kpv-vs-bpc-157)
- [GHK-Cu vs BPC-157](https://pepvault.app/peptides/compare/ghk-cu-vs-bpc-157)
- [BPC-157 vs Thymosin Beta-4](https://pepvault.app/peptides/compare/bpc-157-vs-thymosin-beta-4)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Intramuscular (IM)](https://pepvault.app/glossary/intramuscular)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Stack](https://pepvault.app/glossary/stack)

## Questions people ask

### How long do BPC-157 and larazotide last?

The half-life of BPC-157 is ~4–6 hours (community estimate for SubQ; not measured in people: in rats and dogs it cleared in under 30 minutes). The half-life of larazotide is very short (local gut action).

### How often are BPC-157 and larazotide taken?

BPC-157: once or twice daily. Routes: SubQ injection, IM injection, oral (less studied). Larazotide: 3x daily with meals. Route: Oral.

### How are BPC-157 and larazotide dosed in research?

The research range for BPC-157 is 200–500 mcg. The research range for larazotide is 0.5–1 mg. Studied in research — not a recommendation.

### What are the common side effects of BPC-157 and larazotide?

For BPC-157, the library lists: nausea (rare), injection site irritation, vivid dreams, dizziness. For larazotide: generally well tolerated, mild GI upset, nausea.

### Are BPC-157 and larazotide taken together?

BPC-157 and larazotide are a common stack: larazotide lists BPC-157 among its common stacks. Three layers of the same problem: larazotide targets the gaps between gut cells, BPC-157 supports deeper repair of the gut lining, and KPV damps the inflammation in between. A common practitioner stack for gut recovery. Commonly reported: calmer digestion over several weeks.

## Each one in full

- [BPC-157: dosage, half-life & reference guide](https://pepvault.app/peptides/bpc-157)
- [Larazotide: dosage, half-life & reference guide](https://pepvault.app/peptides/larazotide)
- [BPC-157 dose guide](https://pepvault.app/lab/dosage/bpc-157)
- [Larazotide dose guide](https://pepvault.app/lab/dosage/larazotide)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking BPC-157 or larazotide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking BPC-157 or larazotide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this comparison

### BPC-157

- [BPC-157: the full reference](https://pepvault.app/peptides/bpc-157)
- [BPC-157 dose guide](https://pepvault.app/lab/dosage/bpc-157)

### Larazotide

- [Larazotide: the full reference](https://pepvault.app/peptides/larazotide)
- [Larazotide dose guide](https://pepvault.app/lab/dosage/larazotide)

### Mixing charts

- [BPC-157 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-5mg)
- [BPC-157 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-10mg)

### Studies

- [BPC-157: 10 of 12 women reported full interstitial cystitis relief](https://pepvault.app/research/bpc-157-lee-2024)
- [BPC-157: 14 of 16 reported knee pain relief in a chart review](https://pepvault.app/research/bpc-157-lee-2021)
- [BPC-157 closed duodenocolic fistulas in rats](https://pepvault.app/research/bpc-157-vukusic-2024)
- [All 6 studies](https://pepvault.app/research#bpc-157)
- [Larazotide: eased GI symptoms in celiac patients on gluten challenge](https://pepvault.app/research/larazotide-hoilat-2022)
- [Larazotide: no gut permeability rise after gluten in celiac patients](https://pepvault.app/research/larazotide-paterson-2007)
- [All 2 studies](https://pepvault.app/research#larazotide)

### Compared with

- [Retatrutide vs BPC-157](https://pepvault.app/peptides/compare/retatrutide-vs-bpc-157)
- [Semaglutide vs BPC-157](https://pepvault.app/peptides/compare/semaglutide-vs-bpc-157)
- [BPC-157 vs TB-500](https://pepvault.app/peptides/compare/bpc-157-vs-tb-500)
- [KPV vs BPC-157](https://pepvault.app/peptides/compare/kpv-vs-bpc-157)
- [GHK-Cu vs BPC-157](https://pepvault.app/peptides/compare/ghk-cu-vs-bpc-157)
- [BPC-157 vs Thymosin Beta-4](https://pepvault.app/peptides/compare/bpc-157-vs-thymosin-beta-4)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Intramuscular (IM)](https://pepvault.app/glossary/intramuscular)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Stack](https://pepvault.app/glossary/stack)

<!--promo-->

PepVault for iPhone

## Taking BPC-157 or larazotide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## More comparisons

- [All peptide comparisons](https://pepvault.app/peptides/compare)
- [Retatrutide vs BPC-157](https://pepvault.app/peptides/compare/retatrutide-vs-bpc-157)
- [Semaglutide vs BPC-157](https://pepvault.app/peptides/compare/semaglutide-vs-bpc-157)
- [BPC-157 vs TB-500](https://pepvault.app/peptides/compare/bpc-157-vs-tb-500)
- [KPV vs BPC-157](https://pepvault.app/peptides/compare/kpv-vs-bpc-157)
- [GHK-Cu vs BPC-157](https://pepvault.app/peptides/compare/ghk-cu-vs-bpc-157)
- [BPC-157 vs Thymosin Beta-4](https://pepvault.app/peptides/compare/bpc-157-vs-thymosin-beta-4)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Healing & recovery peptides](https://pepvault.app/peptides#healing)

## Free tools

- [The Dose Guide](https://pepvault.app/lab/dosage)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
